• Je něco špatně v tomto záznamu ?

The molecular genetic background of familial hypercholesterolemia: data from the Slovak nation-wide survey

D. Gabčová, B. Vohnout, D. Staníková, M. Hučková, M. Kadurová, M. Debreová, M. Kozárová, Ľ. Fábryová, J. Staník, I. Klimeš, K. Rašlová, D. Gašperiková

. 2017 ; 66 (1) : 75-84. [pub] 20161108

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17026013

Familial hypercholesterolemia (FH) is most frequently caused by LDLR or APOB mutations. Therefore, the aim of our study was to examine the genetic background of Slovak patients suspected of FH. Patients with clinical suspicion of FH (235 unrelated probands and 124 family relatives) were recruited throughout Slovakia during the years 2011-2015. The order of DNA analyses in probands was as follows: 1. APOB mutation p.Arg3527Gln by real-time PCR method, 2. direct sequencing of the LDLR gene 3. MLPA analysis of the LDLR gene. We have identified 14 probands and 2 relatives with an APOB mutation p.Arg3527Gln, and 89 probands and 75 relatives with 54 different LDLR mutations. Nine of LDLR mutations were novel (i.e. p.Asp90Glu, c.314-2A>G, p.Asp136Tyr, p.Ser177Pro, p.Lys225_Glu228delinsCysLys, p.Gly478Glu, p.Gly675Trpfs*42, p.Leu680Pro, p.Thr832Argfs*3). This is the first study on molecular genetics of FH in Slovakia encompassing the analysis of whole LDLR gene. Genetic etiology of FH was confirmed in 103 probands (43.8 %). Out of them, 86.4 % of probands carried the LDLR gene mutation and remaining 13.6 % probands carried the p.Arg3527Gln APOB mutation.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17026013
003      
CZ-PrNML
005      
20200715133759.0
007      
ta
008      
170824s2017 xr f 000 0|eng||
009      
AR
024    7_
$a 10.33549/physiolres.933348 $2 doi
035    __
$a (PubMed)27824480
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Gabčová, D. $u DIABGENE Laboratory, Institute of Experimental Endocrinology, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia $7 _AN092808
245    14
$a The molecular genetic background of familial hypercholesterolemia: data from the Slovak nation-wide survey / $c D. Gabčová, B. Vohnout, D. Staníková, M. Hučková, M. Kadurová, M. Debreová, M. Kozárová, Ľ. Fábryová, J. Staník, I. Klimeš, K. Rašlová, D. Gašperiková
520    9_
$a Familial hypercholesterolemia (FH) is most frequently caused by LDLR or APOB mutations. Therefore, the aim of our study was to examine the genetic background of Slovak patients suspected of FH. Patients with clinical suspicion of FH (235 unrelated probands and 124 family relatives) were recruited throughout Slovakia during the years 2011-2015. The order of DNA analyses in probands was as follows: 1. APOB mutation p.Arg3527Gln by real-time PCR method, 2. direct sequencing of the LDLR gene 3. MLPA analysis of the LDLR gene. We have identified 14 probands and 2 relatives with an APOB mutation p.Arg3527Gln, and 89 probands and 75 relatives with 54 different LDLR mutations. Nine of LDLR mutations were novel (i.e. p.Asp90Glu, c.314-2A>G, p.Asp136Tyr, p.Ser177Pro, p.Lys225_Glu228delinsCysLys, p.Gly478Glu, p.Gly675Trpfs*42, p.Leu680Pro, p.Thr832Argfs*3). This is the first study on molecular genetics of FH in Slovakia encompassing the analysis of whole LDLR gene. Genetic etiology of FH was confirmed in 103 probands (43.8 %). Out of them, 86.4 % of probands carried the LDLR gene mutation and remaining 13.6 % probands carried the p.Arg3527Gln APOB mutation.
650    _2
$a dospělí $7 D000328
650    _2
$a ženské pohlaví $7 D005260
650    12
$a zdravotnické přehledy $x metody $7 D006306
650    _2
$a lidé $7 D006801
650    _2
$a hyperlipoproteinemie typ II $x diagnóza $x epidemiologie $x genetika $7 D006938
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a kvantitativní polymerázová řetězová reakce $x metody $7 D060888
650    _2
$a receptory LDL $x genetika $7 D011973
650    _2
$a Slovenská republika $x epidemiologie $7 D018154
650    _2
$a statistika jako téma $x metody $7 D013223
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
700    1_
$a Vohnout, Branislav $7 xx0121651 $u Institute of Nutrition, FOZOS, Slovak Medical University, Bratislava, Slovakia; Coordionation Center for Familial Hyperlipoproteinemias, Slovak Medical University, Bratislava, Slovakia
700    1_
$a Staníková, Daniela $7 xx0229669 $u DIABGENE Laboratory, Institute of Experimental Endocrinology, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia; First Department of Pediatrics, Medical Faculty of Comenius University, Bratislava, Slovakia
700    1_
$a Hučková, Miloslava. $7 xx0229639 $u DIABGENE Laboratory, Institute of Experimental Endocrinology, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia
700    1_
$a Kadurová, M. $7 _AN092809 $u Specialized Outpatient Clinic for FHLP, Poprad, Slovakia
700    1_
$a Debreová, M. $7 _AN090684 $u Pediatric Endocrinology Outpatient Clinic, Poprad, Slovakia
700    1_
$a Kozárová, Miriam $7 xx0306259 $u Pediatric Endocrinology Outpatient Clinic, Poprad, Slovakia
700    1_
$a Fábryová, Ľubomíra $7 xx0072891 $u Metabol Klinik, Bratislava, Slovakia
700    1_
$a Staník, Juraj $7 xx0141427 $u DIABGENE Laboratory, Institute of Experimental Endocrinology, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia
700    1_
$a Klimeš, Iwar, $d 1951- $7 xx0105928 $u DIABGENE Laboratory, Institute of Experimental Endocrinology, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia; Coordionation Center for Familial Hyperlipoproteinemias, Slovak Medical University, Bratislava, Slovakia; Center for Pediatric Research Leipzig, Hospital for Chil dren & Adolescents, University of Leipzig, Germany
700    1_
$a Rašlová, Katarína $7 xx0072890 $u Institute of Nutrition, FOZOS, Slovak Medical University, Bratislava, Slovakia; Coordionation Center for Familial Hyperlipoproteinemias, Slovak Medical University, Bratislava, Slovakia
700    1_
$a Gašperíková, Daniela $7 xx0229628 $u DIABGENE Laboratory, Institute of Experimental Endocrinology, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia;
773    0_
$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 66, č. 1 (2017), s. 75-84
856    41
$u http://www.biomed.cas.cz/physiolres/ $y stránka časopisu
910    __
$a ABA008 $b A 4120 $c 266 $y 4 $z 0
990    __
$a 20170824 $b ABA008
991    __
$a 20200715133756 $b ABA008
999    __
$a ok $b bmc $g 1246211 $s 986961
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 66 $c 1 $d 75-84 $e 20161108 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
LZP    __
$b NLK118 $a Pubmed-20170824

Najít záznam

Citační ukazatele

Možnosti archivace